Activest Wealth Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Activest Wealth Management’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$49	Hold	15	–	–	﹤0.01%	1028
2026 Q2	$54	Hold	15	–	–	﹤0.01%	1287
2026 Q1	$72	Hold	15	–	–	﹤0.01%	1169
2025 Q4	$110	Hold	15	–	–	﹤0.01%	1064
2025 Q3	$246	Hold	15	–	–	﹤0.01%	1007
2025 Q2	$304	Hold	15	–	–	﹤0.01%	929
2025 Q1	$116	Buy	+15	New	+$86	﹤0.01%	962

Other funds holding QNTM

Platform Technology Partners New York $632M AUM 18.8% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Activest Wealth Management's QNTM Position: Q3 2026 in Review

Activest Wealth Management held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q3 2026 at 15 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Activest Wealth Management first reported a position in QNTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $304 in Q2 2025. 7 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.

Activest Wealth Management held 15 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $49 as of Q3 2026.
Activest Wealth Management left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q3 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #1028 holding.
Activest Wealth Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 7 quarters since.
Activest Wealth Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $304 in Q2 2025.
7 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.